Views & Analysis

With the potential for a hard-no-deal Brexit becoming closer to reality with each passing day, the question of

Brexit from the inside: MP’s views on how it will impact pharma

https://pharmaphorum.com/views-and-analysis/brexit-inside-mps-views-impact-pharma/

Market Access/ Views & Analysis/ Views and analysis

Division on European HTA

Leela Barham European Commission, Health Technology Assessment, HTA, HTA impact 0 Comment

There have been aspirations for closer collaboration between European Union (EU) Member States (MS) on Health Technology Assessment

Division on European HTA

https://pharmaphorum.com/views-and-analysis/hta-european-health-technology-assessment-division-progress/

Market Access/ Views & Analysis/ Views and analysis

The NHS and integrated care systems – how can pharma play its part?

Dominic Tyer integrated care systems, NHS, sustainability and transformation partnerships 0 Comment

The concept of joining up health and social care has been around a long time – but now

The NHS and integrated care systems – how can pharma play its part?

https://pharmaphorum.com/views-analysis-market-access/nhs-integrated-care-systems/

Market Access/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis

Live Well: when health and opportunity knocks

Piotr Wnuk CARE International, GlaxoSmithKline, Live Well 0 Comment

Live Well brings health products to the doorsteps of rural Zambians in an innovative partnership between GSK and

Live Well: when health and opportunity knocks

https://pharmaphorum.com/views-analysis-market-access/live-well-health-and-opportunity-knocks/

Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Biosimilar switches and healthcare gains

Amanda Barrell biosimilars, market access, Patient education, patient support programme, shared decision making 0 Comment

Despite being used across Europe for more than a decade, biosimilar medications are still something of a mystery

Biosimilar switches and healthcare gains

https://pharmaphorum.com/market-access-2/biosimilar-switches-and-healthcare-gains/

Market Access/ Views & Analysis/ Views and analysis

Matt Hancock has big shoes to fill as he takes over from Jeremy Hunt

Jack Robinson Department of Health, Department of Health and Social Care, Jeremy Hunt, Matt Hancock, NHS, NHS England 0 Comment

What changes will the appointment of Matt Hancock MP as Secretary of State for Health and Social Care mean for the

Matt Hancock has big shoes to fill as he takes over from Jeremy Hunt

https://pharmaphorum.com/market-access-2/matt-hancock-jeremy-hunt-department-health/

Medicine doctor hand touching computer interface as medical network connection with modern virtual screen, medical technology network concept

Digital/ Market Access/ Views & Analysis/ Views & Analysis/ Views and analysis

Who should pay for HTA?

Leela Barham European Commission, Healthcare Technology Assesment, HTA, NICE 0 Comment

Part of the drive for strengthening EU cooperation on health technology assessment (HTA) is to tackle duplication of

Who should pay for HTA?

https://pharmaphorum.com/views-analysis-digital/who-should-pay-hta/

Market Access/ Patients/ Views & Analysis/ Views & Analysis

Patient centricity makes ethical and commercial sense

louise.bellamy@pharmaphorum.com 0 Comment

Patient centricity is no longer a buzzword, it’s an essential way of conducting business that makes both ethical

Patient centricity makes ethical and commercial sense

https://pharmaphorum.com/views-analysis-market-access/patient-centricity-makes-ethical-and-commercial-sense/

Market Access/ Views & Analysis/ Views and analysis

Will plausibility reign supreme in Lyrica second medical use patent case?

Linda Banks Legal, Patents, pharma law, plausibility 0 Comment

Pharma needs clarity from the Supreme Court on whether the whole scope of a patent claim must be plausible at the time of the application.

Will plausibility reign supreme in Lyrica second medical use patent case?

https://pharmaphorum.com/views-analysis-market-access/will-plausibility-reign-supreme-in-lyrica-second-medical-use-patent-case/

«‹ 25 26 27 28 ›

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

Views & Analysis

Login